While the Senate’s proposal eventually removes credits provided by the Inflation Reduction Act enacted under the Biden ...

Senate Republicans have unveiled a sweeping plan to overhaul the Medicaid program, with changes policy analysts warn could ...

Barclays analysts raised their price target to $200, highlighting greater optimism about Blackwell and the company’s earnings ...

Uncertainty around tariffs during President Donald Trump's second term thus far has been a chief reason the Federal Reserve ...

Here’s the brutal truth: You can’t live your niece’s life for her.

The numbers: Home-builder confidence sank to a two-year low as buyers continue to shun the housing market. Builders are ...

Lennar sees the average price of homes delivered for the current quarter falling to the lowest levels seen in eight years.

Tariffs aren’t yet showing up in inflation data, but that doesn’t mean they won’t in the coming months, says Richard Clarida, ...

All large cryptocurrencies were down during U.S. morning trading on Tuesday, with Sui Sui USD seeing the biggest change, ...

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Patrick Kelly, co-manager of a top-performing Alger fund, wants investors to wake up over AI before they miss a big ...

Simmering trade wars have created a sort of stop-and-start economy — and the latest snapshot of retail sales in May ...